{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:46:11Z","timestamp":1773308771451,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1124\/dmd.107.019612","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:36:04Z","timestamp":1205195764000},"page":"1010-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification and Characterization of Potent CYP2B6 Inhibitors in Woohwangcheongsimwon Suspension, an Herbal Preparation Used in the Treatment and Prevention of Apoplexy in Korea and China"],"prefix":"10.1016","volume":"36","author":[{"given":"Hyunmi","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwon-Bok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hei-Young","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Kwan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeoung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Su","family":"Yea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choong-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hyeon","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.019612_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jep.2004.04.009","article-title":"Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst. f.)","volume":"93","author":"Anke","year":"2004","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.107.019612_bib2","first-page":"453","article-title":"Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development","volume":"58","author":"Baranczewski","year":"2006","journal-title":"Pharmacol Rep"},{"key":"10.1124\/dmd.107.019612_bib3","first-page":"157","article-title":"Fetal hydantoin syndrome with unilateral atypical cleft hand: additional evidence for vascular disruption","volume":"13","author":"De Smet","year":"2002","journal-title":"Genet Couns"},{"key":"10.1124\/dmd.107.019612_bib4","first-page":"23","article-title":"A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry","volume":"29","author":"Dierks","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019612_bib5","series-title":"Introduction to Spectroscopy","author":"Donald","year":"2001"},{"key":"10.1124\/dmd.107.019612_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1124\/dmd.107.019612_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/bmc.169","article-title":"Determination of lamivudine\/stavudine\/efavirenz in human serum using liquid chromatography\/electrospray tandem mass spectrometry with ionization polarity switch","volume":"16","author":"Fan","year":"2002","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/dmd.107.019612_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1054-3589(08)60200-8","article-title":"Role of cytochrome P450 enzymes in drug-drug interactions","volume":"43","author":"Guengerich","year":"1997","journal-title":"Adv Pharmacol"},{"key":"10.1124\/dmd.107.019612_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/bja\/80.6.788","article-title":"Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol","volume":"80","author":"Guitton","year":"1998","journal-title":"Br J Anaesth"},{"key":"10.1124\/dmd.107.019612_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2125.2002.01683.x","article-title":"St John\u2019s wort (Hypericum perforatum): drug interactions and clinical outcomes","volume":"54","author":"Henderson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.107.019612_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2133\/dmpk.20.34","article-title":"Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract","volume":"20","author":"Iwata","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.107.019612_bib12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/gast.1997.v113.agast971131408","article-title":"Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death","volume":"113","author":"Kaplowitz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.107.019612_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"key":"10.1124\/dmd.107.019612_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5352\/JLS.2007.17.3.334","article-title":"Screening for inhibitory effect on nine CYP isoforms by 20 herbal medications","volume":"17","author":"Kim","year":"2007","journal-title":"Kor J Life Sci"},{"key":"10.1124\/dmd.107.019612_bib15","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/rcm.2110","article-title":"High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography\/tandem mass spectrometry","volume":"19","author":"Kim","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.107.019612_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ctcp.2004.10.002","article-title":"Perceptions, knowledge and misuse of an oriental herbal drug: a survey of 608 Korean female nursing college students","volume":"11","author":"Lee","year":"2005","journal-title":"Complement Ther Clin Pract"},{"key":"10.1124\/dmd.107.019612_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2005.12.029","article-title":"Herbal monoterpene alcohols inhibit propofol metabolism and prolong anesthesia time","volume":"79","author":"Li Lin","year":"2006","journal-title":"Life Sci"},{"key":"10.1124\/dmd.107.019612_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmj.329.7456.27","article-title":"Interaction of St John\u2019s wort with conventional drugs: systematic review of clinical trials","volume":"329","author":"Mills","year":"2004","journal-title":"BMJ"},{"key":"10.1124\/dmd.107.019612_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0006-2952(02)01444-2","article-title":"Inhibition of acetylcholine-mediated effects by borneol","volume":"65","author":"Park","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.019612_bib20","series-title":"Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems","author":"Segel","year":"1975"},{"key":"10.1124\/dmd.107.019612_bib21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019612_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00498259409043299","article-title":"Use of proton NMR spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient","volume":"24","author":"Sneyd","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.107.019612_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.mej.0000134721.72356.f7","article-title":"Physician knowledge of herbal toxicities and adverse herb-drug interactions","volume":"11","author":"Suchard","year":"2004","journal-title":"Eur J Emerg Med"},{"key":"10.1124\/dmd.107.019612_bib24","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1021\/jf0105034","article-title":"Composition and antimicrobial activity of the essential oils of Micromeria cristata subsp. phrygia and the enantiomeric distribution of borneol","volume":"49","author":"Tabanca","year":"2001","journal-title":"J Agric Food Chem"},{"key":"10.1124\/dmd.107.019612_bib25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/dmd.32.6.626","article-title":"Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro","volume":"32","author":"Turpeinen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019612_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1254\/jjp.89.267","article-title":"Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes","volume":"89","author":"Ueng","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/dmd.107.019612_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.019612_bib28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00008571-200412000-00007","article-title":"Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole","volume":"14","author":"Yin","year":"2004","journal-title":"Pharmacogenetics"}],"updated-by":[{"DOI":"10.1016\/s0090-9556(24)01767-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000}}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624016726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624016726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.019612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:21:55Z","timestamp":1739895715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624016726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0090955624016726"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.019612","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/S0090-9556(24)01767-7","asserted-by":"object"}]},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and Characterization of Potent CYP2B6 Inhibitors in Woohwangcheongsimwon Suspension, an Herbal Preparation Used in the Treatment and Prevention of Apoplexy in Korea and China","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.019612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}